Further studies found that inhibition of CXCL8 and its receptor chemokines CXCR1 and CXCR2 promote G1 cell cycle arrest and apoptosis, suggesting that CXCR1 and CXCR2 inhibit tumor progression in prostate cancer by influencing cell proliferation. Here, CXCR1 is linked to neoplasm.